Aditxt Implements 1-for-113 Reverse Stock Split to Maintain Nasdaq Listing

Aditxt Inc. is executing a dramatic reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, a critical move for maintaining its public market presence.

October 30, 2025
Aditxt Implements 1-for-113 Reverse Stock Split to Maintain Nasdaq Listing

Aditxt Inc. (NASDAQ: ADTX) will implement a 1-for-113 reverse stock split of its common stock effective at the opening of trading on November 3, 2025. The biotechnology company, which describes itself as a social innovation platform accelerating promising health innovations, will see every 113 shares of issued and outstanding common stock convert into one share, with fractional shares being rounded up. The stock will continue trading under the symbol ADTX following this corporate action.

The reverse stock split represents one of the most aggressive corporate restructuring moves seen in recent market history, with the 113-to-1 ratio indicating significant pressure on the company's stock price. This drastic measure was approved by stockholders on September 23, 2025, and is specifically intended to help the company regain compliance with Nasdaq's minimum bid price requirement. Public companies listed on the Nasdaq exchange must maintain a minimum bid price of $1.00 per share to remain in compliance with listing standards.

The implications of this reverse stock split extend beyond mere technical compliance. For current shareholders, the consolidation will dramatically reduce the number of outstanding shares while proportionally increasing the price per share. This corporate action typically occurs when a company's stock price has fallen to levels that threaten its exchange listing eligibility. Failure to maintain Nasdaq listing standards could result in delisting, which would severely limit the stock's liquidity and accessibility to institutional investors.

Aditxt operates through a unique innovation platform that brings together research institutions, industry partners, and shareholders to drive its mission of making promising health innovations possible through collaboration. The company currently manages four distinct programs focused on autoimmunity, cancer and early disease detection, infectious diseases, and women's health. Additional information about the company's developments can be found in its newsroom at https://ibn.fm/ADTX.

While reverse stock splits do not fundamentally change a company's market capitalization, they often signal underlying challenges in the business's performance or market perception. The success of this corporate action in maintaining Aditxt's Nasdaq listing will depend on whether the post-split stock price can sustain levels above the $1.00 threshold. Investors and market analysts will be closely monitoring the stock's performance following the November 3rd implementation date to assess whether this measure provides the intended stability for the company's public market presence.

Aditxt Implements 1-for-113 Reverse Stock Split to Maintain Nasdaq Listing | Boostify